Anticytoplasmic antibodies in antinuclear antibody-negative lupus erythematosus. Correlation with clinical course

Mark S. Paller; W. Scott Moore; Eng Tan; Robert W. Schrier

doi:10.1016/0002-9343(83)90361-3

Anticytoplasmic antibodies in antinuclear antibody-negative lupus erythematosus. Correlation with clinical course

Mark S. Paller, W. Scott Moore, Eng Tan, Robert W. Schrier

Administration (AHC)

Research output: Contribution to journal › Article › peer-review

3 Scopus citations

Abstract

A patient with clinical manifestations of systemic lupus erythematosus (SLE) and without antinuclear antibodies was found to have anticytoplasmic antibodies. These anticytoplasmic antibodies were directed against ribosomal ribonucleoprotein, and the titer of anticytoplasmic and anti-ribosomal ribonucleoprotein antibodies correlated with the clinical course of the patient's illness. The importance of detecting anticytoplasmic antibodies and their role in producing disease in patients with SLE is discussed.

Original language	English (US)
Pages (from-to)	529-533
Number of pages	5
Journal	The American Journal of Medicine
Volume	75
Issue number	3
DOIs	https://doi.org/10.1016/0002-9343(83)90361-3
State	Published - Sep 1983

Bibliographical note

Copyright:
Copyright 2014 Elsevier B.V., All rights reserved.

Access

10.1016/0002-9343(83)90361-3

Cite this

@article{eaed439237f64d41ba998be3d521ec4a,

title = "Anticytoplasmic antibodies in antinuclear antibody-negative lupus erythematosus. Correlation with clinical course",

abstract = "A patient with clinical manifestations of systemic lupus erythematosus (SLE) and without antinuclear antibodies was found to have anticytoplasmic antibodies. These anticytoplasmic antibodies were directed against ribosomal ribonucleoprotein, and the titer of anticytoplasmic and anti-ribosomal ribonucleoprotein antibodies correlated with the clinical course of the patient's illness. The importance of detecting anticytoplasmic antibodies and their role in producing disease in patients with SLE is discussed.",

author = "Paller, {Mark S.} and Moore, {W. Scott} and Eng Tan and Schrier, {Robert W.}",

year = "1983",

month = sep,

doi = "10.1016/0002-9343(83)90361-3",

language = "English (US)",

volume = "75",

pages = "529--533",

journal = "American Journal of Medicine",

issn = "0002-9343",

publisher = "Elsevier Inc.",

number = "3",

}

TY - JOUR

T1 - Anticytoplasmic antibodies in antinuclear antibody-negative lupus erythematosus. Correlation with clinical course

AU - Paller, Mark S.

AU - Moore, W. Scott

AU - Tan, Eng

AU - Schrier, Robert W.

PY - 1983/9

Y1 - 1983/9

N2 - A patient with clinical manifestations of systemic lupus erythematosus (SLE) and without antinuclear antibodies was found to have anticytoplasmic antibodies. These anticytoplasmic antibodies were directed against ribosomal ribonucleoprotein, and the titer of anticytoplasmic and anti-ribosomal ribonucleoprotein antibodies correlated with the clinical course of the patient's illness. The importance of detecting anticytoplasmic antibodies and their role in producing disease in patients with SLE is discussed.

AB - A patient with clinical manifestations of systemic lupus erythematosus (SLE) and without antinuclear antibodies was found to have anticytoplasmic antibodies. These anticytoplasmic antibodies were directed against ribosomal ribonucleoprotein, and the titer of anticytoplasmic and anti-ribosomal ribonucleoprotein antibodies correlated with the clinical course of the patient's illness. The importance of detecting anticytoplasmic antibodies and their role in producing disease in patients with SLE is discussed.

UR - http://www.scopus.com/inward/record.url?scp=0020608662&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020608662&partnerID=8YFLogxK

U2 - 10.1016/0002-9343(83)90361-3

DO - 10.1016/0002-9343(83)90361-3

M3 - Article

C2 - 6351611

AN - SCOPUS:0020608662

VL - 75

SP - 529

EP - 533

JO - American Journal of Medicine

JF - American Journal of Medicine

SN - 0002-9343

IS - 3

ER -

Anticytoplasmic antibodies in antinuclear antibody-negative lupus erythematosus. Correlation with clinical course

Abstract

Bibliographical note

Access

Other files and links

Fingerprint

Cite this